Abstract
Sphingosine 1-phosphate (S1P) is a well-defined bioactive lipid molecule derived from membrane sphingolipid metabolism. In the past decades, a series of key enzymes involved in generation of S1P have been identified and characterized in detail, as well as enzymes degrading S1P. S1P requires transporter to cross the plasma membrane and carrier to deliver to its cognate receptors and therefore transduces signaling in autocrine, paracrine, or endocrine fashions. The essential roles in regulation of development, metabolism, inflammation, and many other aspects of life are mainly executed when S1P binds to receptors provoking the downstream signaling cascades in distinct cells. This chapter will review the synthesis, degradation, transportation, and signaling of S1P and try to provide a comprehensive view of the biology of S1P, evoking new enthusiasms and ideas into the field of the fascinating S1P.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Blaho, V. A., & Hla, T. (2011). Regulation of mammalian physiology, development, and disease by the sphingosine 1-phosphate and lysophosphatidic acid receptors. Chemical Reviews, 111, 6299–6320.
Engelbrecht, E., MacRae, C. A., & Hla, T. (2021). Lysolipids in vascular development, biology, and disease. Arteriosclerosis, Thrombosis, and Vascular Biology, 41, 564–584.
Melendez, A. J., Carlos-Dias, E., Gosink, M., Allen, J. M., & Takacs, L. (2000). Human sphingosine kinase: Molecular cloning, functional characterization and tissue distribution. Gene, 251, 19–26.
Nava, V. E., Lacana, E., Poulton, S., Liu, H., Sugiura, M., Kono, K., Milstien, S., Kohama, T., & Spiegel, S. (2000). Functional characterization of human sphingosine kinase-1. FEBS Letters, 473, 81–84.
Pitson, S. M., D’andrea, R. J., Vandeleur, L., Moretti, P. A., Xia, P., Gamble, J. R., Vadas, M. A., & Wattenberg, B. W. (2000). Human sphingosine kinase: Purification, molecular cloning and characterization of the native and recombinant enzymes. The Biochemical Journal, 350(Pt 2), 429–441.
Liu, H., Sugiura, M., Nava, V. E., Edsall, L. C., Kono, K., Poulton, S., Milstien, S., Kohama, T., & Spiegel, S. (2000). Molecular cloning and functional characterization of a novel mammalian sphingosine kinase type 2 isoform. The Journal of Biological Chemistry, 275, 19513–19520.
Kohama, T., Olivera, A., Edsall, L., Nagiec, M. M., Dickson, R., & Spiegel, S. (1998). Molecular cloning and functional characterization of murine sphingosine kinase. The Journal of Biological Chemistry, 273, 23722–23728.
Alemany, R., van Koppen, C. J., Danneberg, K., Ter Braak, M., Heringdorf, M. Z., & D. (2007). Regulation and functional roles of sphingosine kinases. Naunyn-Schmiedeberg’s Archives of Pharmacology, 374, 413–428.
Yokota, S., Taniguchi, Y., Kihara, A., Mitsutake, S., & Igarashi, Y. (2004). Asp177 in C4 domain of mouse sphingosine kinase 1a is important for the sphingosine recognition. FEBS Letters, 578, 106–110.
Wang, Z., Min, X., Xiao, S. H., Johnstone, S., Romanow, W., Meininger, D., Xu, H., Liu, J., Dai, J., An, S., Thibault, S., & Walker, N. (2013). Molecular basis of sphingosine kinase 1 substrate recognition and catalysis. Structure, 21, 798–809.
Berdyshev, E. V., Gorshkova, I. A., Usatyuk, P., Zhao, Y., Saatian, B., Hubbard, W., & Natarajan, V. (2006). De novo biosynthesis of dihydrosphingosine-1-phosphate by sphingosine kinase 1 in mammalian cells. Cellular Signalling, 18, 1779–1792.
Kharel, Y., Lee, S., Snyder, A. H., Sheasley-O’neill, S. L., Morris, M. A., Setiady, Y., Zhu, R., Zigler, M. A., Burcin, T. L., Ley, K., Tung, K. S. K., Engelhard, V. H., Macdonald, T. L., Pearson-White, S., & Lynch, K. R. (2005). Sphingosine kinase 2 is required for modulation of lymphocyte traffic by FTY720. The Journal of Biological Chemistry, 280, 36865–36872.
Don, A. S., Martinez-Lamenca, C., Webb, W. R., Proia, R. L., Roberts, E., & Rosen, H. (2007). Essential requirement for sphingosine kinase 2 in a sphingolipid apoptosis pathway activated by FTY720 analogues. The Journal of Biological Chemistry, 282, 15833–15842.
Billich, A., Bornancin, F., Devay, P., Mechtcheriakova, D., Urtz, N., & Baumruker, T. (2003). Phosphorylation of the immunomodulatory drug FTY720 by sphingosine kinases. The Journal of Biological Chemistry, 278, 47408–47415.
Paugh, S. W., Payne, S. G., Barbour, S. E., Milstien, S., & Spiegel, S. (2003). The immunosuppressant FTY720 is phosphorylated by sphingosine kinase type 2. FEBS Letters, 554, 189–193.
Hengst, J. A., Guilford, J. M., Fox, T. E., Wang, X., Conroy, E. J., & Yun, J. K. (2009). Sphingosine kinase 1 localized to the plasma membrane lipid raft microdomain overcomes serum deprivation induced growth inhibition. Archives of Biochemistry and Biophysics, 492, 62–73.
Kusner, D. J., Thompson, C. R., Melrose, N. A., Pitson, S. M., Obeid, L. M., & Iyer, S. S. (2007). The localization and activity of sphingosine kinase 1 are coordinately regulated with actin cytoskeletal dynamics in macrophages. The Journal of Biological Chemistry, 282, 23147–23162.
Thompson, C. R., Iyer, S. S., Melrose, N., VanOosten, R., Johnson, K., Pitson, S. M., Obeid, L. M., & Kusner, D. J. (2005). Sphingosine kinase 1 (SK1) is recruited to nascent phagosomes in human macrophages: Inhibition of SK1 translocation by Mycobacterium tuberculosis. Journal of Immunology, 174, 3551–3561.
Pitson, S. M., Moretti, P. A., Zebol, J. R., Lynn, H. E., Xia, P., Vadas, M. A., & Wattenberg, B. W. (2003). Activation of sphingosine kinase 1 by ERK1/2-mediated phosphorylation. The EMBO Journal, 22, 5491–5500.
Jarman, K. E., Moretti, P. A., Zebol, J. R., & Pitson, S. M. (2010). Translocation of sphingosine kinase 1 to the plasma membrane is mediated by calcium- and integrin-binding protein 1. The Journal of Biological Chemistry, 285, 483–492.
Igarashi, N., Okada, T., Hayashi, S., Fujita, T., Jahangeer, S., & Nakamura, S. (2003). Sphingosine kinase 2 is a nuclear protein and inhibits DNA synthesis. The Journal of Biological Chemistry, 278, 46832–46839.
Ding, G., Sonoda, H., Yu, H., Kajimoto, T., Goparaju, S. K., Jahangeer, S., Okada, T., & Nakamura, S. I. (2007). Protein kinase D-mediated phosphorylation and nuclear export of sphingosine kinase 2. The Journal of Biological Chemistry, 282, 27493–27502.
Hait, N. C., Allegood, J., Maceyka, M., Strub, G. M., Harikumar, K. B., Singh, S. K., Luo, C., Marmorstein, R., Kordula, T., Milstien, S., & Spiegel, S. (2009). Regulation of histone acetylation in the nucleus by sphingosine-1-phosphate. Science, 325, 1254–1257.
Strub, G. M., Paillard, M., Liang, J., Gomez, L., Allegood, J. C., Hait, N. C., Maceyka, M., Price, M. M., Chen, Q., Simpson, D. C., Kordula, T., Milstien, S., Lesnefsky, E. J., & Spiegel, S. (2011). Sphingosine-1-phosphate produced by sphingosine kinase 2 in mitochondria interacts with prohibitin 2 to regulate complex IV assembly and respiration. The FASEB Journal, 25, 600–612.
Maceyka, M., Sankala, H., Hait, N. C., Le Stunff, H., Liu, H., Toman, R., Collier, C., Zhang, M., Satin, L. S., Merrill, A. H., Jr., Milstien, S., & Spiegel, S. (2005). SphK1 and SphK2, sphingosine kinase isoenzymes with opposing functions in sphingolipid metabolism. The Journal of Biological Chemistry, 280, 37118–37129.
Weigert, A., Cremer, S., Schmidt, M. V., von Knethen, A., Angioni, C., Geisslinger, G., & Brüne, B. (2010). Cleavage of sphingosine kinase 2 by caspase-1 provokes its release from apoptotic cells. Blood, 115, 3531–3540.
Allende, M. L., Sasaki, T., Kawai, H., Olivera, A., Mi, Y., van Echten-Deckert, G., Hajdu, R., Rosenbach, M., Keohane, C. A., Mandala, S., Spiegel, S., & Proia, R. L. (2004). Mice deficient in sphingosine kinase 1 are rendered lymphopenic by FTY720. The Journal of Biological Chemistry, 279, 52487–52492.
Mizugishi, K., Yamashita, T., Olivera, A., Miller, G. F., Spiegel, S., & Proia, R. L. (2005). Essential role for sphingosine kinases in neural and vascular development. Molecular and Cellular Biology, 25, 11113–11121.
Feuerborn, R., Besser, M., Poti, F., Burkhardt, R., Weissen-Plenz, G., Ceglarek, U., Simoni, M., Proia, R. L., Freise, H., & Nofer, J. R. (2018). Elevating endogenous sphingosine-1-phosphate (S1P) levels improves endothelial function and ameliorates atherosclerosis in low density lipoprotein receptor-deficient (LDL-R−/−) mice. Thrombosis and Haemostasis, 118, 1470–1480.
Zemann, B., Kinzel, B., Muller, M., Reuschel, R., Mechtcheriakova, D., Urtz, N., Bornancin, F., Baumruker, T., & Billich, A. (2006). Sphingosine kinase type 2 is essential for lymphopenia induced by the immunomodulatory drug FTY720. Blood, 107, 1454–1458.
Michaud, J., Kohno, M., Proia, R. L., & Hla, T. (2006). Normal acute and chronic inflammatory responses in sphingosine kinase 1 knockout mice. FEBS Letters, 580, 4607–4612.
Grin’kina, N. M., Karnabi, E. E., Damania, D., Wadgaonkar, S., Muslimov, I. A., & Wadgaonkar, R. (2012). Sphingosine kinase 1 deficiency exacerbates LPS-induced neuroinflammation. PLoS One, 7, e36475.
Galvani, S., Sanson, M., Blaho, V. A., Swendeman, S. L., Obinata, H., Conger, H., Dahlback, B., Kono, M., Proia, R. L., Smith, J. D., & Hla, T. (2015). HDL-bound sphingosine 1-phosphate acts as a biased agonist for the endothelial cell receptor S1P1 to limit vascular inflammation. Science Signaling, 8, ra79.
Pyne, S., Kong, K. C., & Darroch, P. I. (2004). Lysophosphatidic acid and sphingosine 1-phosphate biology: The role of lipid phosphate phosphatases. Seminars in Cell & Developmental Biology, 15, 491–501.
Zhou, J., & Saba, J. D. (1998). Identification of the first mammalian sphingosine phosphate lyase gene and its functional expression in yeast. Biochemical and Biophysical Research Communications, 242, 502–507.
Tang, X., Benesch, M. G., & Brindley, D. N. (2015). Lipid phosphate phosphatases and their roles in mammalian physiology and pathology. Journal of Lipid Research, 56, 2048–2060.
Giussani, P., Maceyka, M., Le Stunff, H., Mikami, A., Lepine, S., Wang, E., Kelly, S., Merrill, A. H., Jr., Milstien, S., & Spiegel, S. (2006). Sphingosine-1-phosphate phosphohydrolase regulates endoplasmic reticulum-to-golgi trafficking of ceramide. Molecular and Cellular Biology, 26, 5055–5069.
Le Stunff, H., Giussani, P., Maceyka, M., Lepine, S., Milstien, S., & Spiegel, S. (2007). Recycling of sphingosine is regulated by the concerted actions of sphingosine-1-phosphate phosphohydrolase 1 and sphingosine kinase 2. The Journal of Biological Chemistry, 282, 34372–34380.
Le Stunff, H., Galve-Roperh, I., Peterson, C., Milstien, S., & Spiegel, S. (2002). Sphingosine-1-phosphate phosphohydrolase in regulation of sphingolipid metabolism and apoptosis. The Journal of Cell Biology, 158, 1039–1049.
Johnson, K. R., Johnson, K. Y., Becker, K. P., Bielawski, J., Mao, C., & Obeid, L. M. (2003). Role of human sphingosine-1-phosphate phosphatase 1 in the regulation of intra- and extracellular sphingosine-1-phosphate levels and cell viability. The Journal of Biological Chemistry, 278, 34541–34547.
Allende, M. L., Sipe, L. M., Tuymetova, G., Wilson-Henjum, K. L., Chen, W., & Proia, R. L. (2013). Sphingosine-1-phosphate phosphatase 1 regulates keratinocyte differentiation and epidermal homeostasis. The Journal of Biological Chemistry, 288, 18381–18391.
Taguchi, Y., Allende, M. L., Mizukami, H., Cook, E. K., Gavrilova, O., Tuymetova, G., Clarke, B. A., Chen, W., Olivera, A., & Proia, R. L. (2016). Sphingosine-1-phosphate phosphatase 2 regulates pancreatic islet β-cell endoplasmic reticulum stress and proliferation. The Journal of Biological Chemistry, 291, 12029–12038.
Stoffel, W., LeKim, D., & Sticht, G. (1969). Distribution and properties of dihydrosphingosine-1-phosphate aldolase (sphinganine-1-phosphate alkanal-lyase). Hoppe-Seyler’s Zeitschrift für Physiologische Chemie, 350, 1233–1241.
Bourquin, F., Riezman, H., Capitani, G., & Grutter, M. G. (2010). Structure and function of sphingosine-1-phosphate lyase, a key enzyme of sphingolipid metabolism. Structure, 18, 1054–1065.
Borowsky, A. D., Bandhuvula, P., Kumar, A., Yoshinaga, Y., Nefedov, M., Fong, L. G., Zhang, M., Baridon, B., Dillard, L., de Jong, P., Young, S. G., West, D. B., & Saba, J. D. (2012). Sphingosine-1-phosphate lyase expression in embryonic and adult murine tissues. Journal of Lipid Research, 53, 1920–1931.
Schwab, S. R., Pereira, J. P., Matloubian, M., Xu, Y., Huang, Y., & Cyster, J. G. (2005). Lymphocyte sequestration through S1P lyase inhibition and disruption of S1P gradients. Science, 309, 1735–1739.
Saba, J. D. (2019). Fifty years of lyase and a moment of truth: Sphingosine phosphate lyase from discovery to disease. Journal of Lipid Research, 60, 456–463.
Schmahl, J., Raymond, C. S., & Soriano, P. (2007). PDGF signaling specificity is mediated through multiple immediate early genes. Nature Genetics, 39, 52–60.
Weber, C., Krueger, A., Munk, A., Bode, C., Van Veldhoven, P. P., & Graler, M. H. (2009). Discontinued postnatal thymocyte development in sphingosine 1-phosphate-lyase-deficient mice. Journal of Immunology, 183, 4292–4301.
Vogel, P., Donoviel, M. S., Read, R., Hansen, G. M., Hazlewood, J., Anderson, S. J., Sun, W., Swaffield, J., & Oravecz, T. (2009). Incomplete inhibition of sphingosine 1-phosphate lyase modulates immune system function yet prevents early lethality and non-lymphoid lesions. PLoS One, 4, e4112.
Allende, M. L., Bektas, M., Lee, B. G., Bonifacino, E., Kang, J., Tuymetova, G., Chen, W., Saba, J. D., & Proia, R. L. (2011). Sphingosine-1-phosphate lyase deficiency produces a pro-inflammatory response while impairing neutrophil trafficking. The Journal of Biological Chemistry, 286, 7348–7358.
Bektas, M., Allende, M. L., Lee, B. G., Chen, W., Amar, M. J., Remaley, A. T., Saba, J. D., & Proia, R. L. (2010). Sphingosine 1-phosphate lyase deficiency disrupts lipid homeostasis in liver. The Journal of Biological Chemistry, 285, 10880–10889.
Hagen, N., Van Veldhoven, P. P., Proia, R. L., Park, H., Merrill, A. H., & van Echten-Deckert, G. (2009). Subcellular origin of sphingosine 1-phosphate is essential for its toxic effect in lyase-deficient neurons. The Journal of Biological Chemistry, 284, 11346–11353.
Degagne, E., Pandurangan, A., Bandhuvula, P., Kumar, A., Eltanawy, A., Zhang, M., Yoshinaga, Y., Nefedov, M., de Jong, P. J., Fong, L. G., Young, S. G., Bittman, R., Ahmedi, Y., & Saba, J. D. (2014). Sphingosine-1-phosphate lyase downregulation promotes colon carcinogenesis through STAT3-activated microRNAs. The Journal of Clinical Investigation, 124, 5368–5384.
Morgan, A. R., Turic, D., Jehu, L., Hamilton, G., Hollingworth, P., Moskvina, V., Jones, L., Lovestone, S., Brayne, C., Rubinsztein, D. C., Lawlor, B., Gill, M., O’Donovan, M. C., Owen, M. J., & Williams, J. (2007). Association studies of 23 positional/functional candidate genes on chromosome 10 in late-onset Alzheimer’s disease. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics, 144B, 762–770.
Hla, T., Venkataraman, K., & Michaud, J. (2008). The vascular S1P gradient-cellular sources and biological significance. Biochimica et Biophysica Acta, 1781, 477–482.
Fukuhara, S., Simmons, S., Kawamura, S., Inoue, A., Orba, Y., Tokudome, T., Sunden, Y., Arai, Y., Moriwaki, K., Ishida, J., Uemura, A., Kiyonari, H., Abe, T., Fukamizu, A., Hirashima, M., Sawa, H., Aoki, J., Ishii, M., & Mochizuki, N. (2012). The sphingosine-1-phosphate transporter Spns2 expressed on endothelial cells regulates lymphocyte trafficking in mice. The Journal of Clinical Investigation, 122, 1416–1426.
Hisano, Y., Kobayashi, N., Yamaguchi, A., & Nishi, T. (2012). Mouse SPNS2 functions as a sphingosine-1-phosphate transporter in vascular endothelial cells. PLoS One, 7, e38941.
Nijnik, A., Clare, S., Hale, C., Chen, J., Raisen, C., Mottram, L., Lucas, M., Estabel, J., Ryder, E., Adissu, H., Sanger Mouse Genetics Project, Adams, N. C., Ramirez-Solis, R., White, J. K., Steel, K. P., Dougan, G., & Hancock, R. E. (2012). The role of sphingosine-1-phosphate transporter Spns2 in immune system function. Journal of Immunology, 189, 102–111.
Mendoza, A., Breart, B., Ramos-Perez, W. D., Pitt, L. A., Gobert, M., Sunkara, M., Lafaille, J. J., Morris, A. J., & Schwab, S. R. (2012). The transporter Spns2 is required for secretion of lymph but not plasma sphingosine-1-phosphate. Cell Reports, 2, 1104–1110.
Mendoza, A., Fang, V., Chen, C., Serasinghe, M., Verma, A., Muller, J., Chaluvadi, V. S., Dustin, M. L., Hla, T., Elemento, O., Chipuk, J. E., & Schwab, S. R. (2017). Lymphatic endothelial S1P promotes mitochondrial function and survival in naive T cells. Nature, 546, 158–161.
Fang, V., Chaluvadi, V. S., Ramos-Perez, W. D., Mendoza, A., Baeyens, A., Rivera, R., Chun, J., Cammer, M., & Schwab, S. R. (2017). Gradients of the signaling lipid S1P in lymph nodes position natural killer cells and regulate their interferon-gamma response. Nature Immunology, 18, 15–25.
Wang, Z., Zheng, Y., Wang, F., Zhong, J., Zhao, T., Xie, Q., Zhu, T., Ma, F., Tang, Q., Zhou, B., & Zhu, J. (2020). Mfsd2a and Spns2 are essential for sphingosine-1-phosphate transport in the formation and maintenance of the blood-brain barrier. Science Advances, 6, eaay8627.
Vu, T. M., Ishizu, A. N., Foo, J. C., Toh, X. R., Zhang, F., Whee, D. M., Torta, F., Cazenave-Gassiot, A., Matsumura, T., Kim, S., Toh, S. E. S., Suda, T., Silver, D. L., Wenk, M. R., & Nguyen, L. N. (2017). Mfsd2b is essential for the sphingosine-1-phosphate export in erythrocytes and platelets. Nature, 550, 524–528.
Chandrakanthan, M., Nguyen, T. Q., Hasan, Z., Muralidharan, S., Vu, T. M., Li, A. W. L., Le, U. T. N., Ha, H. T. T., Baik, S.-H., Tan, S. H., Foo, J. C., Wenk, M. R., Cazenave-Gassiot, A., Torta, F., Ong, W. Y., Chan, M. Y. Y., & Nguyen, L. N. (2021). Deletion of Mfsd2b impairs thrombotic functions of platelets. Nature Communications, 12, 2286.
Okuniewska, M., Fang, V., Baeyens, A., Raghavan, V., Lee, J. Y., Littman, D. R., & Schwab, S. R. (2021). SPNS2 enables T cell egress from lymph nodes during an immune response. Cell Reports, 36, 109368.
Kawahara, A., Nishi, T., Hisano, Y., Fukui, H., Yamaguchi, A., & Mochizuki, N. (2009). The sphingolipid transporter spns2 functions in migration of zebrafish myocardial precursors. Science, 323, 524–527.
Kobayashi, N., Kawasaki-Nishi, S., Otsuka, M., Hisano, Y., Yamaguchi, A., & Nishi, T. (2018). MFSD2B is a sphingosine 1-phosphate transporter in erythroid cells. Scientific Reports, 8, 4969.
Cater, R. J., Chua, G. L., Erramilli, S. K., Keener, J. E., Choy, B. C., Tokarz, P., Chin, C. F., Quek, D. Q. Y., Kloss, B., Pepe, J. G., Parisi, G., Wong, B. H., Clarke, O. B., Marty, M. T., Kossiakoff, A. A., Khelashvili, G., Silver, D. L., & Mancia, F. (2021). Structural basis of omega-3 fatty acid transport across the blood-brain barrier. Nature, 595, 315–319.
Wood, C. A. P., Zhang, J., Aydin, D., Xu, Y., Andreone, B. J., Langen, U. H., Dror, R. O., Gu, C., & Feng, L. (2021). Structure and mechanism of blood-brain-barrier lipid transporter MFSD2A. Nature, 596, 444–448.
Jumper, J., Evans, R., Pritzel, A., Green, T., Figurnov, M., Ronneberger, O., Tunyasuvunakool, K., Bates, R., Zidek, A., Potapenko, A., Bridgland, A., Meyer, C., Kohl, S. A. A., Ballard, A. J., Cowie, A., Romera-Paredes, B., Nikolov, S., Jain, R., Adler, J., … Hassabis, D. (2021). Highly accurate protein structure prediction with AlphaFold. Nature, 596, 583–589.
Murata, N., Sato, K., Kon, J., Tomura, H., Yanagita, M., Kuwabara, A., Ui, M., & Okajima, F. (2000). Interaction of sphingosine 1-phosphate with plasma components, including lipoproteins, regulates the lipid receptor-mediated actions. The Biochemical Journal, 352(Pt 3), 809–815.
Obinata, H., Kuo, A., Wada, Y., Swendeman, S., Liu, C. H., Blaho, V. A., Nagumo, R., Satoh, K., Izumi, T., & Hla, T. (2019). Identification of ApoA4 as a sphingosine 1-phosphate chaperone in ApoM- and albumin-deficient mice. Journal of Lipid Research, 60, 1912–1921.
Christoffersen, C., Obinata, H., Kumaraswamy, S. B., Galvani, S., Ahnstrom, J., Sevvana, M., Egerer-Sieber, C., Muller, Y. A., Hla, T., Nielsen, L. B., & Dahlback, B. (2011). Endothelium-protective sphingosine-1-phosphate provided by HDL-associated apolipoprotein M. Proceedings of the National Academy of Sciences of the United States of America, 108, 9613–9618.
Liu, M., Seo, J., Allegood, J., Bi, X., Zhu, X., Boudyguina, E., Gebre, A. K., Avni, D., Shah, D., Sorci-Thomas, M. G., Thomas, M. J., Shelness, G. S., Spiegel, S., & Parks, J. S. (2014). Hepatic apolipoprotein M (apoM) overexpression stimulates formation of larger apoM/sphingosine 1-phosphate-enriched plasma high density lipoprotein. The Journal of Biological Chemistry, 289, 2801–2814.
Ruiz, M., Okada, H., & Dahlback, B. (2017). HDL-associated ApoM is anti-apoptotic by delivering sphingosine 1-phosphate to S1P1 & S1P3 receptors on vascular endothelium. Lipids in Health and Disease, 16, 36.
Ruiz, M., Frej, C., Holmer, A., Guo, L. J., Tran, S., & Dahlback, B. (2017). High-density lipoprotein-associated Apolipoprotein M limits endothelial inflammation by delivering Sphingosine-1-Phosphate to the Sphingosine-1-Phosphate Receptor 1. Arteriosclerosis, Thrombosis, and Vascular Biology, 37, 118–129.
Swendeman, S. L., Xiong, Y., Cantalupo, A., Yuan, H., Burg, N., Hisano, Y., Cartier, A., Liu, C. H., Engelbrecht, E., Blaho, V., Zhang, Y., Yanagida, K., Galvani, S., Obinata, H., Salmon, J. E., Sanchez, T., Di Lorenzo, A., & Hla, T. (2017). An engineered S1P chaperone attenuates hypertension and ischemic injury. Science Signaling, 10(492), eaal2722.
Bode, C., Sensken, S. C., Peest, U., Beutel, G., Thol, F., Levkau, B., Li, Z., Bittman, R., Huang, T., Tolle, M., van der Giet, M., & Graler, M. H. (2010). Erythrocytes serve as a reservoir for cellular and extracellular sphingosine 1-phosphate. Journal of Cellular Biochemistry, 109, 1232–1243.
Kurano, M., & Yatomi, Y. (2018). Sphingosine 1-phosphate and atherosclerosis. Journal of Atherosclerosis and Thrombosis, 25, 16–26.
Chun, J., Hla, T., Lynch, K. R., Spiegel, S., & Moolenaar, W. H. (2010). International Union of Basic and Clinical Pharmacology. LXXVIII. Lysophospholipid receptor nomenclature. Pharmacological Reviews, 62, 579–587.
Foord, S. M., Bonner, T. I., Neubig, R. R., Rosser, E. M., Pin, J. P., Davenport, A. P., Spedding, M., & Harmar, A. J. (2005). International Union of Pharmacology. XLVI. G protein-coupled receptor list. Pharmacological Reviews, 57, 279–288.
Blaho, V. A., & Hla, T. (2014). An update on the biology of sphingosine 1-phosphate receptors. Journal of Lipid Research, 55, 1596–1608.
Means, C. K., & Brown, J. H. (2009). Sphingosine-1-phosphate receptor signalling in the heart. Cardiovascular Research, 82, 193–200.
Li, C., Kong, Y., Wang, H., Wang, S., Yu, H., Liu, X., Yang, L., Jiang, X., Li, L., & Li, L. (2009). Homing of bone marrow mesenchymal stem cells mediated by sphingosine 1-phosphate contributes to liver fibrosis. Journal of Hepatology, 50, 1174–1183.
Kono, Y., Nishiuma, T., Nishimura, Y., Kotani, Y., Okada, T., Nakamura, S., & Yokoyama, M. (2007). Sphingosine kinase 1 regulates differentiation of human and mouse lung fibroblasts mediated by TGF-beta1. American Journal of Respiratory Cell and Molecular Biology, 37, 395–404.
Zhang, X., Ritter, J. K., & Li, N. (2018). Sphingosine-1-phosphate pathway in renal fibrosis. American Journal of Physiology. Renal Physiology, 315, F752–F756.
Engelbrecht, E., Levesque, M. V., He, L., Vanlandewijck, M., Nitzsche, A., Niazi, H., Kuo, A., Singh, S. A., Aikawa, M., Holton, K., Proia, R. L., Kono, M., Pu, W. T., Camerer, E., Betsholtz, C., & Hla, T. (2020). Sphingosine 1-phosphate-regulated transcriptomes in heterogenous arterial and lymphatic endothelium of the aorta. eLife, 9, e52690.
Ramos-Perez, W. D., Fang, V., Escalante-Alcalde, D., Cammer, M., & Schwab, S. R. (2015). A map of the distribution of sphingosine 1-phosphate in the spleen. Nature Immunology, 16, 1245–1252.
Hisano, Y., Kono, M., Cartier, A., Engelbrecht, E., Kano, K., Kawakami, K., Xiong, Y., Piao, W., Galvani, S., Yanagida, K., Kuo, A., Ono, Y., Ishida, S., Aoki, J., Proia, R. L., Bromberg, J. S., Inoue, A., & Hla, T. (2019). Lysolipid receptor cross-talk regulates lymphatic endothelial junctions in lymph nodes. The Journal of Experimental Medicine, 216, 1582–1598.
Shi, X., Wang, W., Li, J., Wang, T., Lin, Y., Huang, S., Kuver, A., Chen, C., Hla, T., Li, X., & Dai, K. (2019). Sphingosine 1-phosphate receptor 1 regulates cell-surface localization of membrane proteins in endothelial cells. Biochimica et Biophysica Acta—General Subjects, 1863, 1079–1087.
Wang, B., Dong, N., Wu, D., Fang, Y., Chen, J., Lin, Y., Bellusci, S., Zhang, J. S., Dai, K., & Chen, C. (2022). Sphingosine 1-phosphate receptor 1 governs endothelial barrier function and angiogenesis by upregulating endoglin signaling. Annals of Translational Medicine, 10(3), 136. https://doi.org/10.21037/atm-21-6679
Hanson, M. A., Roth, C. B., Jo, E., Griffith, M. T., Scott, F. L., Reinhart, G., Desale, H., Clemons, B., Cahalan, S. M., Schuerer, S. C., Sanna, M. G., Han, G. W., Kuhn, P., Rosen, H., & Stevens, R. C. (2012). Crystal structure of a lipid G protein-coupled receptor. Science, 335, 851–855.
Schulze, T., Golfier, S., Tabeling, C., Rabel, K., Graler, M. H., Witzenrath, M., & Lipp, M. (2011). Sphingosine-1-phospate receptor 4 (S1P(4)) deficiency profoundly affects dendritic cell function and TH17-cell differentiation in a murine model. The FASEB Journal, 25, 4024–4036.
Walzer, T., Chiossone, L., Chaix, J., Calver, A., Carozzo, C., Garrigue-Antar, L., Jacques, Y., Baratin, M., Tomasello, E., & Vivier, E. (2007). Natural killer cell trafficking in vivo requires a dedicated sphingosine 1-phosphate receptor. Nature Immunology, 8, 1337–1344.
Jaillard, C., Harrison, S., Stankoff, B., Aigrot, M. S., Calver, A. R., Duddy, G., Walsh, F. S., Pangalos, M. N., Arimura, N., Kaibuchi, K., Zalc, B., & Lubetzki, C. (2005). Edg8/S1P5: An oligodendroglial receptor with dual function on process retraction and cell survival. The Journal of Neuroscience, 25, 1459–1469.
Novgorodov, A. S., El-Alwani, M., Bielawski, J., Obeid, L. M., & Gudz, T. I. (2007). Activation of sphingosine-1-phosphate receptor S1P5 inhibits oligodendrocyte progenitor migration. The FASEB Journal, 21, 1503–1514.
Acknowledgments
The authors thank Dr. Beibei Wang (Department of Respiratory Medicine, The First Affiliated Hospital of Wenzhou Medical University) for initial preparation and selection of reference papers and proofreading of the manuscript. This work is supported by the Natural Science Foundation of Zhejiang Province (LY20C070002).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 The Author(s), under exclusive licence to Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Hu, Y., Dai, K. (2022). Sphingosine 1-Phosphate Metabolism and Signaling. In: Jiang, XC. (eds) Sphingolipid Metabolism and Metabolic Disease. Advances in Experimental Medicine and Biology, vol 1372. Springer, Singapore. https://doi.org/10.1007/978-981-19-0394-6_6
Download citation
DOI: https://doi.org/10.1007/978-981-19-0394-6_6
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-19-0393-9
Online ISBN: 978-981-19-0394-6
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)